Hello, Fool! | Login | Signup | My Fool
Dec 3, 2008 4:54 PM ET | Feedback | Site Changes | Help
The Company is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products.
View All Commentary (KG)
Recs
fct44 (92.55) Submitted: 2/19/07 3:32 PM : Start Price: $18.02 KG Score: 7.79
Showed potential for growth four years ago, but to many acquisitions caused earnings to slow. Stock is at the same price I paid for it four years ago, although recent activity has the stock price up lately, I don't expect this trend to continue with greater generic competition and patents that will end soon. Don't expect the stock to grow over $20 for quite some time.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK